<DOC>
	<DOCNO>NCT00097058</DOCNO>
	<brief_summary>This study design assess effect estrogen therapy among postmenopausal woman risk cognitive decline .</brief_summary>
	<brief_title>Estrogen Use Protection From Cognitive Decline</brief_title>
	<detailed_description>A total 71 postmenopausal woman age 50-65 estrogen therapy randomize continue discontinue use estrogen follow two year . Participants undergo PET MRI scan neuropsychological assessment initially end two-year follow-up period . These procedure allow u evaluate brain metabolism cognitive performance baseline two year follow continuation discontinuation estrogen therapy . We hypothesize woman discontinue estrogen show evidence decline continue estrogen . This project expand current knowledge effect estrogen 1 ) determine whether estrogen use among postmenopausal woman risk cognitive decline protective brain metabolism , 2 ) identify early predictor cognitive decline , 3 ) develop guideline estrogen use postmenopausal woman .</detailed_description>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>Women age 45 65 Currently hormone replacement One year post complete cessation menses Willing sign Human Subject Protection Consent form prior enrollment study Willing randomize continue discontinue estrogen therapy Adequately visually auditorially acute allow neuropsychological test Beyond 8 year educational achievement allow adequate neuropsychological test Willing undergo brain imaging At risk cognitive decline , define one following : Personal family history mood disorder , Hypothyroidism , Diabetes , Family history Alzheimer 's , APOE4 allele Diagnosis possible probable Alzheimer 's disease dementia Cerebrovascular disease uncontrolled hypertension ( systolic BP &gt; 170 diastolic BP &gt; 100 ) History myocardial infarction within previous year unstable heart disease History significant liver disease , pulmonary disease , current cancer Contraindication MRI ( metal body , claustrophobia , etc . )</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Aging</keyword>
	<keyword>Menopause</keyword>
	<keyword>Estrogen Replacement Therapy</keyword>
	<keyword>Cognitive Decline</keyword>
</DOC>